Adjuvant trastuzumab in HER2-positive breast cancer

Collins, Ian, Francis, P and Mileshkin, L 2012, Adjuvant trastuzumab in HER2-positive breast cancer, The New England journal of medicine, vol. 366, pp. 664-664, doi: 10.1056/NEJMc1112823#SA3.

Attached Files
Name Description MIMEType Size Downloads

Title Adjuvant trastuzumab in HER2-positive breast cancer
Author(s) Collins, IanORCID iD for Collins, Ian
Francis, P
Mileshkin, L
Journal name The New England journal of medicine
Volume number 366
Start page 664
End page 664
Total pages 1
Publisher Massachusetts Medical Society
Publication date 2012
ISSN 0028-4793
Keyword(s) Antibodies, Monoclonal/*therapeutic use Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Breast Neoplasms/*drug therapy Female Humans *Receptor, erbB-2
Notes Collins, Ian Francis, Prudence Mileshkin, Linda eng Comment Letter 2012/02/18 06:00 N Engl J Med. 2012 Feb 16;366(7):664; author reply 664-6. doi: 10.1056/NEJMc1112823#SA3.
Language eng
DOI 10.1056/NEJMc1112823#SA3
Field of Research 110399 Clinical Sciences not elsewhere classified
11 Medical And Health Sciences
Socio Economic Objective 970111 Expanding Knowledge in the Medical and Health Sciences
HERDC Research category C4.1 Letter or note
Persistent URL

Document type: Journal Article
Collections: Faculty of Health
School of Medicine
Connect to link resolver
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 5 times in TR Web of Science
Scopus Citation Count Cited 4 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 64 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Fri, 14 Aug 2015, 09:00:54 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact